Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer
ConclusionThere was no significant difference in the RAI ablation success rate between the low-dose and high-dose groups involving patients with intermediate-to-high-risk DTC. However, high-dose RAI ablation may be recommended in high-risk patients.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hormones | Iodine | Nuclear Medicine | Study | Thyroid | Thyroid Cancer | Thyroidectomy | Women